Epicor Kinetic
Epicor Kinetic is a cloud-first, AI-powered ERP platform for manufacturing environments that require a connected system for transactional, operational, and reporting workflows. The platform supports finance, supply chain, production, inventory, quality, service, analytics, project management, governance and compliance, and global business management. Functional coverage includes planning and scheduling, materials management, shop floor coordination, product management, CRM, field service, electronic reporting, and enterprise content management. Kinetic provides browser-based access, role-based workflows, integration and extensibility tools, IIoT-related capabilities, and deployment options for cloud, on-premises, or hybrid architectures. It can integrate with listed third-party systems for payroll, tax, labeling, procurement, warehouse processes, data capture, and quality workflows, including ADP Workforce Now, Avalara, BarTender, Sage, SourceDay, and Sovos. Epicor Prism adds AI-supported automation and decision support for selected workflows. Kinetic also supports operations across the Americas, EMEA, and APAC and is available in multiple languages, which can matter for distributed manufacturing organizations with regional or multinational requirements.
Learn more
TraceEngine
The world's leading authority on case management systems has developed a software dedicated to skip tracing. TraceEngine will make skip tracing faster, easier, and more efficient. It is powered by PoloniousEngine, and benefits from the 20 years of experience with world-class investigation and system delivery software. Cloud-based hosting and security is taken care of and you can be up and running within 10 minutes. Your first 30 days are free. You can get our ongoing support at $165 per month. There are no contracts and you can cancel any time. TraceEngine has powerful features designed specifically for skip tracing, allowing you to manage more cases and generate additional business. You can easily assign cases to investigators using a simple search and select tool. If the details are not in the system, a widget will appear to allow you to add them.
Learn more
Medis Suite XA
Medis Suite XA serves as our comprehensive solution for X-Ray angiography, built upon over three decades of expertise in cardiovascular image analysis. This all-inclusive package features an array of modules, including a user-friendly viewer and various analyses dedicated to coronary and vascular assessments, enabling detailed anatomical evaluations of arteries. It also encompasses analyses for both left and right ventricles along with integrated reporting capabilities. Among its offerings are advanced analyses for coronary and peripheral vessels (QCA and QVA) as well as left and right ventriculograms (QLV and QRV). A standout feature is the innovative QFR® analysis, which evaluates the functional significance of lesions without requiring adenosine or a pressure wire. Moreover, the suite allows for seamless integration within the healthcare IT infrastructure, ensuring effortless connectivity with the DICOM network, thus enhancing workflow efficiency and patient care. Ultimately, Medis Suite XA represents a significant advancement in the field of cardiovascular imaging.
Learn more
Artrya
Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.
Learn more